IP Library Granted Patent US 8,426,460
Granted Patent B2
US 8,426,460 · App. 12/631,249 · Granted Apr 23, 2013

Dimeric avermectin and milbemycin derivatives

Inventor: Charles Q. Meng (Johns Creek, GA)
Assignee: Merial Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,426,460
App. No.
12/631,249
Granted
Apr 23, 2013
Kind
B2
Abstract

This invention provides for novel antiparasitic and pesticidal derivatives of avermectin and milbemycin compounds in which two avermectin or milbemycin members are linked together by a chemical linker. The resulting compounds may be used in veterinary compositions which are used in treating, controlling and preventing of endo- and ectoparasite infections and infestations in animals or for combating pests in plants or plant propagation material.

Claims (90)

1. A compound of formula (I) or a pharmaceutically acceptable salt thereof:

wherein:

A is a single or double bond;

B is a single or double bond;

R 1 and R 5 are independently hydrogen, hydroxyl, oxo, oximino or alkoxyimino, provided that R 1 is hydroxyl only when A is a single bond, and that R 5 is hydroxyl only when B is a single bond;

R 2 and R 6 are independently linear or branched C 1 -C 8 alkyl, C 2 -C 8 alkenyl, or C 3 -C 8 cycloalkyl;

R 3 and R 7 are independently hydroxyl, methoxy, oxo, hydroximino, or alkoxyimino;

R 4 and R 8 are independently hydrogen, hydroxyl, C 1 -C 8 alkanoyloxy, benzoyloxy, di-C 1 -C 8 alkylamino benzoyloxy, (C 1 -C 8 alkoxy) p , C 1 -C 8 alkylthio, C 1 -C 8 alkylthioalkoxy or oleandrosyloxy;

R 9 and R 10 are independently diradical groups selected from a bond, O, NR 11 , —NR 11 C(═O)—, —NR 11 C(═S)—, —NR 11 C(═O)O—, —ONR 11 C(═O)—, —ONR 11 C(═O)O—, —ONR 11 C(═O)NR 11 —, —OC(═O)O—, —N(R 11 )C(═O)N(R 11 )—, —N(R 11 )C(═S)N(R 11 )—, —N(R 11 )S(O) 2 N(R 11 )—, —N(R 11 )S(O) 2 —, —N(R 11 )S(O)N(R 11 )—, —N(R 11 )S(O)—, —C(═NR 11 )—, —C(═O)—, —C(═O)N(R 11 )—, and —C(═S)N(R 11 )—;

R 11 is H or R 2 ;

L is a diradical linker selected from a bond, C 1 -C 20 alkylene, C 2 -C 20 alkenylene, C 2 -C 20 alkynylene, C 3 -C 8 cycloalkylene, arylene, aryloxy arylene, heteroarylene, or any combination thereof, which may optionally contain a N, O, S, P, or Si atom; and

wherein said linker may optionally be substituted with one or more groups selected from cyano, nitro, hydroxy, halogen, O, N, S, C 1 -C 6 alkyl, C 3 -C 8 cycloalkyl, C 1 -C 6 alkoxy, C 1 -C 6 thioalkyl, oxo, oximino, and alkoxyimino;

m and n are independently 1, or 2; and

p is 1-3; wherein R 9 and R 10 may be connected to any two atoms of linker L.

2. The compound of claim 1 wherein:

A and B are both double bonds; and

n and m are 2.

3. The compound of claim 1 wherein:

A and B are both single bonds; and

n and m are 2.

4. The compound of claim 1 , wherein R 3 and R 7 are independently hydroxyl or methoxy; and R 2 and R 6 are independently sec-butyl or iso-propyl.

5. The compound of claim 1 , wherein R 1 and R 5 are independently hydrogen or hydroxyl.

6. The compound of claim 1 wherein L is C 1 -C 20 alkylene or arylene;

and R 9 and R 10 are independently O, NR 11 , —NR 11 C(═O)—, —NR 11 C(═O)O—, —ONR 11 C(═O)—, —ONR 11 C(═O)O—, —ONR 11 C(═O)NR 11 —, —OC(═O)O—, —N(R 11 )C(═O)N(R 11 )—, —N(R 11 )S(O) 2 —, or —N(R 11 )S(O)N(R 11 )—.

7. The compound of claim 1 wherein:

R 1 and R 5 are independently hydrogen or hydroxyl;

R 2 and R 6 are independently sec-butyl, iso-propyl or cyclohexyl;

R 3 and R 7 are hydroxyl, methoxy or hydroximino;

R 4 and R 8 are hydrogen;

R 9 and R 10 are independently nitrogen or oxygen; and

L is C 2 -C 20 alkylene or arylene; and

m and n are independently 2.

8. The compound of claim 1 wherein:

R 1 and R 5 are independently hydrogen or hydroxyl;

R 2 and R 6 are independently sec-butyl, iso-propyl or cyclohexyl;

R 3 and R 7 are hydroxyl, methoxy or hydroximino;

R 4 and R 8 are hydrogen;

R 9 and R 10 are independently —NR 11 C(═O)—, —NR 11 C(═O)O—, —ONR 11 C(═O)—, —ONR 11 C(═O)O—, —ONR 11 C(═O)NR 11 —, —OC(═O)O—, —N(R 11 )C(═O)N(R 11 )—, —N(R 11 )S(O) 2 —, or —N(R 11 )S(O)N(R 11 )—; and

L is C 2 -C 20 alkylene or arylene; and

m and n are independently 2.

9. The compound of claim 1 wherein:

A is a double bond;

B is a double bond;

R 1 and R 5 are hydrogen;

R 2 and R 6 are independently isopropyl or sec-butyl;

R 3 and R 7 are hydroxyl or methoxy;

R 4 and R 8 are hydrogen;

R 9 and R 10 are independently oxygen or NR 11 ; and

L is C 2 -C 10 alkylene or arylene.

10. The compound of claim 1 wherein:

A is a double bond;

B is a double bond;

R 1 and R 5 are hydrogen;

R 2 and R 6 are independently iso-propyl or sec-butyl;

R 3 and R 7 are hydroxyl, methoxy or hydroxyimino;

R 4 and R 8 are hydrogen;

R 9 and R 10 are independently —NR 11 C(═O)—, —NR 11 C(═O)O—, —ONR 11 C(═O)—, —ONR 11 C(═O)O—, —ONR 11 C(═O)NR 11 —, —N(R 11 )C(═O)N(R 11 )—, or —N(R 11 )S(O) 2 —; and

L is C 2 -C 10 alkylene or arylene.

11. The compound of claim 1 wherein:

A is a single bond;

B is a single bond;

R 1 and R 5 are hydrogen;

R 2 and R 6 are independently iso-propyl or sec-butyl;

R 3 and R 7 are hydroxyl, methoxy or hydroximino;

R 4 and R 8 are hydrogen;

R 9 and R 10 are independently —NR 11 C(═O)—, —NR 11 C(═O)O—, —ONR 11 C(═O)—, —ONR 11 C(═O)O—, —ONR 11 C(═O)NR 11 —, —N(R 11 )C(═O)N(R 11 )—, or —N(R 11 )S(O) 2 —; and

L is C 2 -C 10 alkylene or arylene.

12. The compound of claim 10 or 11 wherein:

R 3 and R 7 are hydroxyl;

R 9 and R 10 are independently —NR 11 C(═O)—, —NR 11 C(═O)O—, —ONR 11 C(═O)—, —ONR 11 C(═O)O—, —ONR 11 C(═O)NR 11 —, or —N(R 11 )C(═O)N(R 11 )—; and

L is C 2 -C 10 alkylene.

13. The compound of claim 10 or 11 wherein:

R 3 and R 7 are hydroxyl;

R 9 and R 10 are independently —NR 11 C(═O)—, —NR 11 C(═O)O—, —ONR 11 C(═O)—, —ONR 11 C(═O)O—, —ONR 11 C(═O)NR 11 —, or —N(R 11 )C(═O)N(R 11 )—; and

L is phenylene.

14. The compound of claim 12 , wherein:

R 9 and R 10 are independently —ONR 11 C(═O)—, —ONR 11 C(═O)O—, —ONR 11 C(═O)NR 11 —, or —N(R 11 )C(═O)N(R 11 )—;

R 11 is hydrogen or C 1 -C 8 alkyl; and

m and n are 2.

15. The compound of claim 12 , wherein:

R 9 and R 10 are independently —ONR 11 C(═O)—, —ONR 11 C(═O)O—, —ONR 11 C(═O)NR 11 —, or —N(R 11 )C(═O)N(R 11 )—;

R 11 is hydrogen or C 1 -C 8 alkyl; and

m and n are 0.

16. The compound of claim 13 , wherein:

R 9 and R 10 are independently —ONR 11 C(═O)—, —ONR 11 C(═O)O—, —ONR 11 C(═O)NR 11 —, or —N(R 11 )C(═O)N(R 11 )—;

R 11 is hydrogen or C 1 -C 8 alkyl; and

m and n are 2.

17. A composition for the treatment of a parasitic infection in an animal comprising at least one compound of claim 1 , or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

18. A composition for combating pests in plants or plant propagation material comprising at least one compound of claim 1 , or an agriculturally acceptable salt thereof, and an agriculturally acceptable carrier.

19. A method for treating an endoparasitic infection in an animal comprising administering an effective amount of the compound of claim 1 , or a pharmaceutically acceptable salt thereof, to an animal in need thereof, wherein said endoparasitic infection is caused by an endoparasite selected from the group consisting of Anaplocephala, Ancylostoma, Anecator, Ascaaris, Capillaria, Cooperia, Dipylidium, Dirofilaria, Echinococcus, Enterobius, Fasciola, Haemonchus, Oesophagostumum, Ostertagia, Toxocara, Strongyloides, Toxascaris, Trichinella, Trichuris and Trichostrongylus.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2016
From: MERIAL LIMITED
To: MERIAL, INC.
Reel/Frame 038995/0104 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2010
From: MENG, CHARLES Q.
To: MERIAL LIMITED
Reel/Frame 023801/0396 →
Continuity (2)
Provisional Application 61119761 · Dec 4, 2008
Related Publication 20100144859A1 · Jun 10, 2010